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Abstract
The binding of oligomeric peptide-MHC (pMHC) complexes to cell surface TCR can be
considered to approximate TCR-pMHC interactions at cell-cell interfaces. Here, we analyzed the
equilibrium binding of streptavidin-based pMHC oligomers (tetramers) and their dissociation
kinetics from CD8pos T cells from 2C-TCR transgenic mice and from T cell hybridomas that
expressed the 2C TCR or a high-affinity mutant (m33) of this TCR. Our results show that the
tetramers did not come close to saturating cell-surface TCR (binding only 10-30% of cell-surface
receptors), as is generally assumed in deriving affinity values (KD), in part because of dissociative
losses from tetramer-stained cells. Guided by a kinetic model, the oligomer dissociation rate and
equilibrium constants were seen to depend not only on monovalent association and dissociation
rates (koff and kon), but on a multivalent association rate (μ) and TCR cell-surface density. Our
results suggest that dissociation rates could account for the recently described surprisingly high
frequency of tetramer-negative, functionally competent T cells in some T cell responses.
Introduction
Since antibodies and many antigens are soluble, it has been possible to study their
interactions with a variety of methods under conditions that are physiological or nearly so.
For T cell receptors (TCR) and their peptide-MHC ligands (pMHC), however, their natural
state as integral membrane proteins on T cells and antigen-presenting cells limits the options
for analyzing their interactions. Considerable insights have been gleaned from responses of
T cells to pMHC displayed at various levels on other cells (target cells or antigen-presenting
cells, APC). The responses are informative particularly when correlated with measurements
of equilibrium constants and reaction rates, but the latter are most often determined with
recombinant TCR and MHC molecules in the absence of CD8 and CD4 co-receptors. Since
these co-receptors have a pronounced impact on the cellular responses, efforts have been
made to study the binding of soluble pMHC complexes to TCR on intact CD8pos T cells (1).
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As monomers, these complexes are of limited use because they dissociate too rapidly from
TCR (2, 3). However, pMHC oligomers bind more stably. Hence, they are widely used to
identify T cells with cognate TCR and also, though much less widely, to determine TCR-
pMHC affinities and reaction rates. The oligomeric forms include IgG dimers (4) and
pentamers (ProImmune, Ltd., Oxford, UK), but most often, as in the present study,
streptavidin-linked pMHC oligomers, called tetramers (5-7), as originally introducd by
Altman et al (8).
It has been generally accepted that the proportion of T cells that are stained by
chromophore-labelled tetramers accurately measures the frequency of T cells that express
the corresponding (cognate) TCRs. There are reports, however, of CD8+ T cells that respond
specifically to pMHC on target cells, yet are not stained by the same pMHC as tetramers
(9-12). And recently a surprisingly high frequency of CD4+ T cells that are similarly
tetramer-negative but functionally competent has been described in responses to infection by
lymphocytic choriomeningitis virus and especially to a self-antigen (myelin oligodendrocyte
glycoprotein; (13)).
Studies have shown that the intensity of tetramer staining of T cells generally correlates with
monovalent TCR-pMHC affinity and several other variables, including the density of TCR
on T cells, lipid membrane organization, and differentiation status of the cells (activated vs
naïve T cells (12, 14-18). Estimates of the multivalent affinity (avidity) of cell surface TCR
for tetramers are taken as the concentration of free tetramer at half-maximal binding of
tetramer to cells, a determination that assumes saturation of surface TCR by bound tetramers
at high free tetramer concentration. This assumption was questioned by a recent study (19)
in which a panel of TCR that differed widely in affinity for the same pMHC were expressed
in hybridomas that were stained with that pMHC in tetrameric form. Although the TCR
levels were expressed at the same levels in all hybridomas, the maximal levels of tetramer
staining varied considerably, raising the possibility that cell surface TCR were not saturated
in any of the cells tested.
To evaluate this possibility, we here analyzed the equilibrium binding of pMHC tetramers
and their dissociation kinetics from CD8pos T cells from 2C-TCR transgenic mice and
transduced T cell hybridomas that expressed the 2C TCR (20) or an engineered high-affinity
mutant (m33 (21)) of this TCR. The analyses were based on a kinetic model of multimeric
pMHC binding to cell surface TCR. The results establish that tetramers did not come close
to saturating cell-surface TCR, in part because of their dissociation when tetramer-stained
cells are washed. Besides the intrinsic (monovalent) association and dissociation rates,
critical determinants of tetramer dissociation are the multivalent association rate (μ) and the
2-dimensional concentration (density) of cell-surface TCR. The rapidity of dissociation of
tetramers from some TCR can account for the frequency of tetramer-negative, functionally
competent T cells.
Materials and Methods
Peptides, antibodies, and cells
SIY (SIYRYYGL) and OVA (SIINFEKL) peptides were synthesized by the
Macromolecular Core Facility of the Section of Research Sources, Penn State College of
Medicine. Peptides were purified by reverse phase chromatography using a C-18 column,
and masses were confirmed by MALDI. Peptide quantification by amino acid analysis was
performed at the Molecular Structure Facility, UC Davis (Davis, CA).
Fluorescein-labeled monoclonal antibodies (F23.1, H57-597, 145-2C11, 53-6.7, 53-5.8) and
streptavidin were purchased from BD Pharmingen (San Jose, CA). The 1B2 anti-2C TCR
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and B.8.24.3 anti-Kb monoclonal antibodies were purified from hybridoma supernatant
using protein G beads. 1B2 was labeled with FITC, and purified to remove excess FITC. For
each fluorescein-labeled protein, the protein concentration and number of fluorescein
molecules per protein molecule was determined by comparing the ratio of UV-Vis
absorbance at 495 nm and 280 nm (phosphate buffered saline, pH 7.4), using a molar
extinction coefficient of 69,000 for fluorescein at 495nm, and subtracting 0.2 x A495 from
the absorbance at 280nm to yield protein absorbance and concentration. Multiple
independent dilutions of each protein were scanned to determine the fluorescein to protein
ratio. Protein molar extinction coefficients were taken as ε280=176,000 for streptavidin, and
ε280=210,000 for antibodies.
58−/− T cell hybridomas retrovirally transduced with various T cell receptor genes, with or
without co-expression of CD8αβ, were maintained in RPMI-1640 supplemented with 10%
fetal calf serum, L-glutamine, penicillin and streptomycin. Splenic T cells from 2C TCR
transgenic mice on a RAG−/− background or from C57BL/6 mice were purified by negative
selection of non-T cells with magnetic beads (Dynal, Invitrogen, Carlsbad, CA). DIC
microscopy was performed using an Olympus BX51 microscope, and cell size
measurements were made using the Microsuite software (Olympus America, Center Valley,
PA)
Protein Expression and Preparation
Single chain Vβ-linker-Vα TCR (scTCR) were expressed as inclusion bodies in BL21(DE3)
E. coli (Stratagene, La Jolla, CA). The stable single chain 2C TCR that includes an inter-
domain flexible linker (22) has been previously shown to maintain binding specificity for all
ligands tested, and binding measured by surface plasmon resonance has shown identical
binding affinity and kinetics for the scTCR and full length, soluble TCR without a linker
(23, 24). Proteins were solubilized in urea and refolded by dilution as previously described
(19). The refolded protein was purified by binding to Ni-NTA agarose beads (Qiagen,
Valencia, CA), followed by elution in 500mM imidizole, followed by size exclusion
chromatography over a Superdex 200 gel filtration column (GE Healthcare, Piscataway,
NJ).
H2-Kb heavy chain containing a C-terminal biotinylation signal peptide and mouse and
human β2m light chains were expressed separately in E. coli. H2-Kb heavy chain was
biotinylated in vivo by co-induction of biotin ligase, so that the heavy chain carried a biotin
tag (25). Both chains were expressed as inclusion bodies, solubilized in urea and refolded
together in vitro in the presence of excess SIY or OVA peptide (19). Folded complexes were
purified by anion exchange chromatography using HiTrap Q columns (GE Healthcare,
Piscataway, NJ) and size exclusion chromatography. For incorporation of SIY/Kb into
streptavidin oligomers, pre-characterized, calibrated, fluorescein-labeled streptavidin was
added stepwise to the biotinylated SIY/Kb complexes in small aliquots on ice over 20
minutes to various final molar ratios. Characterization of the resulting oligomer complex
distribution was performed by SDS-PAGE.
Binding Measurements of Soluble Receptors at 10°C
Kinetic and equilibrium binding data was obtained by surface plasmon resonance (SPR)
using a BIAcore 3000 (Biacore Life Sciences, GE Healthcare, Piscataway, NJ) pre-cooled to
10°C. Biotinylated SIY/Kb and OVA/Kb monomers were immobilized on a neutravidin-
coated CM5 sensor chip on different flow cells to approximately 400 response units. Soluble
scTCRs were purified by size-exclusion chromatography no more than 24 hours before
making measurements to avoid aggregates. The scTCRs were flowed over the SIY/Kb and
OVA/Kb at various concentrations in Biacore buffer (20mM HEPES, 150mM NaCl, 3mM
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EDTA, 0.005% Tween-20, pH 7.4) at 30μL/minute. Binding of scTCRs to the null complex
OVA/Kb was subtracted from TCR binding to SIY/Kb to correct for bulk shift and any non-
specific binding. On-rates, off-rates, and kinetic-based KD analyses were performed using
BIAEvaluation 3.0 software.
Oligomer Binding and Dissociation Experiments
To perform steady-state oligomer binding titrations, 58−/− cells transduced with TCR genes
(2C, m33, or other mutants) or T cells purified from 2C transgenic or C57BL/6 mouse
splenocytes were incubated with various concentrations of fluorescein-labeled streptavidin
SIY/Kb oligomers in FACS buffer (1% bovine serum albumin in phosphate-buffered saline
with 0.02% sodium azide) on ice for at least 2 hours in the dark. After an 8 minute wash in
cold (ca 10°C) FACS buffer, cells were resuspended in cold FACS buffer and analyzed for
bound fluorescent tetramers by flow cytometry. Fluorescence levels of the parental 58−/−
cell line (control) were subtracted as background from the TCR transfected hybridoma
values at the same staining concentration.
Oligomer dissociation experiments were performed as described previously (19, 26-28).
Briefly, 58−/− cells transfected with mutant TCR chains or 2C TCR transgenic T cells
purified from mouse splenocytes were stained with 293nM (or 5.85μM for 2C TCR
hybridomas without CD8αβ) streptavidin-linked SIY/Kb tetramers on ice for 2 hours. Cells
were washed and resuspended in 25°C dissociation buffer containing 2% FCS, 0.1% azide,
100μM Cytochalasin D, and 200μg/mL Kb-blocking antibody (B.8.24.3, to prevent re-
binding) in RPMI 1620. At various times, cells were diluted in ice-cold PBS containing 1%
BSA and 0.02% azide and analyzed by flow cytometry. Complete dissociation was
determined to be the level of staining observed for the parental 58−/− cell line or for C57BL/
6 cells. Data from dissociation experiments were fit by an equation describing a first order
exponential decay.
Quantification of cell surface-bound antibodies and oligomers
Cells were stained at 4°C in the dark with saturating amounts of calibrated fluorescein-
labeled antibodies (determined by titration), or the indicated levels of SIY/Kb oligomer
made with calibrated fluorescein-labeled streptavidin, for at least 2 hours. The cells were
then washed for 8 minutes at 4°C in a large excess of FACS buffer, and resuspended
immediately prior to analysis by flow cytometry (FACS Canto, BD Biosciences, San Jose,
CA). Quantification of molecules per cell was derived from flow cytometry experiments in
which specific fluorescence was analyzed in relation to calibrated fluorescein beads
(Spherotech, Lake Forest, IL and Bangs Labs, Fishers, IN, Supplementary Figs S1 and S2).
Fluorescent beads were analyzed at the same cytometer settings as the stained cells, and
measured fluorescence values were used to convert corrected cell-bound fluorescence to
numbers of cell-bound fluorescein-molecule equivalents. These latter values were used to
calculate the number of cell-bound antibody molecules or SA-oligomers.
Model
To describe the behavior of streptavidin-linked oligomers binding to and dissociating from T
cells, we developed and applied a quantitative model. As the oligomers used here have on
average three pMHC complexes per SA molecule (Fig. 1A, below), our model assumes that
an SA-oligomer can bind to one, two, or three cell-surface TCR molecules; these various
bound states are described as L − T , L = T , and L ≡ T , where L refers to oligomer (ligand)
and T to TCR. As discussed below (Results) and shown in detail in Appendix A: Model
Equations, a bound oligomer’s effective dissociation rate ( ) is determined by two
parameters: koff (the intrinsic dissociation rate of the pMHC-TCR bond, as measured, for
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example, by SPR) and μ (a multivalent association constant with units of s−1, which is
related to the intrinsic (univalent) pMHC-TCR association rate, kon (with units of M−1s−1),
and an effective concentration of surface T, as discussed below (see Results)).
At equilibrium, the oligomer association and dissociation rates are equal, as described by:
, where  is on-rate for the monomeric pMHC-TCR interaction, as
measured for instance by SPR, modified by the number of pMHC per streptavidin molecule.
If θ, is the fraction of occupied receptors, Tfree = (1 − θ)Ttotal, and Lbound = θTtotal, we can
express the ratio of bound to free receptors as . Eq. 5, which resembles
the Scatchard equation (29-31), then follows. Detailed derivation of the equilibrium
equations (including Eq.5) can be found in Appendix A.
In describing these multivalent binding events, we assume that a pseudo-equilibrium
between the T cell-bound states of an oligomer is reached rapidly compared with the overall
association or dissociation of an oligomer from the T cell. This assumption is justified where
μ >> koff, as is the case for the TCR-pMHC interactions described in this study (μ~10-40-
fold larger than koff). In addition, our interactions are in the range where dissociation data
can be described by an exponential decay curve; a lack of rapid interconversion of bound
states would result in a different shape to the dissociation data (32). In a range where this
assumption is not valid, including much more weakly binding receptors, the amount of
bound oligomer over time could be determined by numerically solving the set of differential
equations defining the interactions in Appendix A (Eq. A1, A2, and A3). Moreover, with the
assumption μ >> koff ,  can be obtained from Eq. 2 in the text, the derivation of which
can be found in the Appendix.
In this model, we also assume no positive or negative cooperativity of binding which could
affect on-rates or off-rates beyond the statistical factors we have applied to μ and koff. While
this assumption may not be fully accurate, there is no clear way to account for such effects.
Based on the successful application of this model to our data, we suspect that any
cooperativity, if present, does not affect our overall conclusions.
Results
Characterization of pMHC streptavidin-linked oligomers (tetramers)
The complexes formed by streptavidin with biotinylated MHC, usually called tetramers,
vary in the number of biotinylated MHC molecules per streptavidin (SA) molecule (33, 34).
Figure 1A shows the distribution of oligomers when biotinylated class I MHC and SA were
combined at different molar ratios. Based on these results, the preparations used for
subsequent work (below) were, assembled with a 16:1 molar ratio of SIY-Kb:SA; they
consisted of approximately 40% trimer, and 20% each tetramer, dimer, and monomer bound
to SA. Because of the size distribution (Fig. 1A), we refer to them hereafter as SA
oligomers, or simply oligomers, rather than as tetramers.
Analysis of steady-state binding of pMHC oligomers to T cells
To relate oligomer binding to TCR affinity, CD8 contribution, and cell surface levels of
TCR and CD8, we first measured the steady-state binding of SIY/Kb oligomers to T cell
hybridomas that expressed the 2C TCR (20) or an engineered, high-affinity mutant (m33
(21)) of this TCR (Fig. 1B), and also to naïve CD8+ 2C T cells freshly isolated from spleens
of 2C TCR transgenic mice (Fig. 1C). CD8α and CD8β were co-expressed in some of the
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hybridomas. After the cells were incubated on ice for 2 hrs with oligomers at various
concentrations, they were dispersed in a large volume of cold buffer, centrifuged, and the
pelleted cells re-suspended immediately before analysis by flow cytometry. The cell-bound
oligomers increased with increasing free oligomer concentration to a maximum level and
reached a plateau, or declined slightly, at the highest concentrations (Figs 1B,C). The
treatment used here is typical of oligomer staining protocols where binding is allowed to
reach steady-state, and the cells are washed prior to analysis by flow cytometry. While these
data may be fit by a sigmoidal curve similar to equilibrium binding data giving a 50% max
value (KD,olig) that can be compared from cell population to cell population, this does not
precisely correspond to a true equilibrium binding constant (see below). To obtain a more
representative equilibrium on a cell surface, techniques such as spinning cells through oil
rapidly to remove unbound ligands (1) or avoiding a wash step entirely (15) have been
employed previously.
As shown in Fig. 1B, SIY-Kb oligomers bound equally well to i) hybridoma cells (58−/−)
that expressed CD8 but not 2C TCR and ii) hybridoma cells that expressed the 2C TCR but
not CD8. This finding is consistent with the similar binding constants found for the binding
of CD8αβ to peptide-Kb (KD = 38 μM, (35)) and 2C TCR to SIY-Kb (KD = 30 μM; (19, 23,
24), see Table IV, below).
The TCR affinity for the oligomers is generally taken to be the free oligomer concentration
when the amount of bound oligomers is half the plateau or maximal level (KD,olig). The ratio
between KD,olig and the equilibrium constant (KD) for monovalent binding of the same TCR
to the same pMHC as monomer (KD,olig/KD, called the enhancement factor) was previously
seen to be more pronounced for low-affinity than high-affinity TCR-pMHC interactions
(19). It was thus not surprising that for m33, the very high-affinity TCR (19), the oligomer
concentration that resulted in half-maximal binding was about the same with CD8pos and
CD8neg hybridomas (Fig. 1B). However, for the much lower affinity wild-type 2C TCR, the
half-maximal concentrations with CD8neg and CD8pos hybridomas, 2.8 nM and 4.8 nM,
respectively, were surprisingly also similar (Fig. 1B); the small difference implied that the
co-expressed CD8 had, if anything, a negative effect on this TCR’s affinity for pMHC.
Among the questions raised by these findings is whether the SA-oligomers can engage all
cell surface TCR and measure TCR affinity for pMHC.
Do oligomers at high concentration saturate cell-surface TCRs?
To determine if saturation is approached, we measured the number of surface TCR
molecules per cell, using fluorescein-labeled monoclonal antibodies to various TCR
domains (Cβ and Vβ8) and to the TCR-associated protein, CD3; we also used the
fluorescein-labeled clonotypic antibody 1B2, which is specific for the 2C TCR (but does not
bind to the 2C mutant m33). The results are shown in Figs. 2A,B, and summarized in Table
I. As noted in the legend to Table I, the number of surface TCR molecules per cell was
estimated to be twice the number of antibody molecules bound (to account for antibody
binding bivalently). The number of TCR may be slightly lower, as some anti-TCR antibody
molecules may be bound monovalently. Studies have shown that while the TCR complex
can assemble as a monomer (36), the TCR may exist on the cell surface, at least in part, as a
dimer (37-39) or oligomer (40, 41), and may preferentially bind antibodies bivalently (39). It
is, of course, possible that not all the TCRs measured by antibody quantification are
conformationally able to bind pMHC at any given time.
As the oligomers are trimeric on average (Fig. 1A), and are thought to behave functionally
as trimers, the number of TCR engaged by bound oligomers was taken to be (at most) three
times the maximum number of bound oligomers in the titrations shown in Figs. 1B,C. From
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the ratio of oligomer-engaged TCR to the total number of TCR it appeared that no more than
10-30 percent of cell surface TCR were maximally engaged by bound oligomers.
Dissociation kinetics of cell-bound tetramers
One possible reason for the apparent failure to engage more cell surface TCR is that bound
oligomers are lost when cells are washed prior to flow cytometry. To evaluate this
possibility, we examined the dissociation of SIY/Kb oligomers from oligomer-stained cells
(Figs. 3A,B). The steps involved in dissociation can be represented by:
(1)
where T refers to available TCR sites on the cell surface, L≡T is the number of oligomers
bound by three pMHC complexes, L=T is the number bound by two pMHCs, and L-T is the
number bound by one pMHC, Dissociation of L-T loses oligomers into solution (Lsol). The
off-rate constants for dissociation (koff) are considered to be the same as measured by
surface plasmon resonance (SPR) with monomeric pMHC except for the statistical factors
shown in Eq. 1. However, the on-rates will differ by more than these statistical factors.
When a TCR monomer binds to immobilized pMHC complexes (as in an SPR experiment),
it gives up the entropic freedom of sampling a multitude of configurations in solution and
orients itself in the correct configuration. This entropic penalty is contained in the free
energy barrier that is included in the measured value of the on-rate constant (kon). The same
entropic factors (with minor differences due to potential steric constraints) are also relevant
when the first pMHC of an oligomer binds, but after one of an oligomer’s pMHC binds to a
cell, the binding rate of the other pMHC of that oligomer is determined by rather different
entropic changes. Therefore, the effective on-rate for the binding of the second and third
pMHC, designated μ, will differ from that obtained from SPR measurements with
monomeric pMHC by more than statistical factors. By assuming that interconversion among
bound states of the oligomer (single, double, or triple-bonded) is relatively rapid, it can be
shown (see Appendix) that
(2),
where Lbound,t is the amount of bound oligomer at a particular time (t), and Lbound,0 is the
amount bound initially.
As seen in Figs 3A,B, the dissociation rates from each of the hybridomas and T cells could
indeed be fitted by a single-value exponential decay constant ( ), which is equivalent to
 in Eq. 2. This suggests that we are in a regime where the
assumption of a rapid interconversion of bound states is valid, as has been assumed
previously (32).
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From the experimentally determined  values (Fig.3), the amounts of oligomer lost during
the approximately 8 min spent in washing oligomer-stained cells (see Materials and
Methods) can be estimated. Correction for these losses still indicated that saturation was far
from having been achieved before washing cells, especially for the freshly isolated CD8pos
splenic T cells. These corrections were based initially on dissociation rates measured at
25°C (Fig. 3A,B). But, as the cells were washed in the cold (about 10°C), where longer t1/2
values are expected, the actual losses were likely even smaller. To find out how much
smaller, we took advantage of the intrinsic (monovalent) on- and off-rates for the binding of
the SIY-Kb complex by the 2C and m33 TCR measured by surface plasmon resonanace
(SPR) at 25°C and 10°C ((19) and Table III). Based upon the following argument, these
intrinsic rates could be used, together with the  measured at 25°C, to estimate  at
10°C.
As is discussed in Appendix A, the difference in dimensions of μ (measured in s−1) and
intrinsic monovalent on-rates, kon (which are measured for reactants in solution and
expressed in M−1s−1) arises because μ already incorporates the TCR concentration in the
form of the cell-surface density in the vicinity of the bound oligomer; i.e., μ = kon x local
surface density of TCR, where kon is essentially the monovalent kon as measured by SPR
(see below). On the assumption that the local and overall cell-surface TCR density for a
given T cell is the same at 25°C and 10°C, it follows that
(3)
Values for kon at the two temperatures are shown in Table III for m33 and several other
engineered mutants of the 2C TCR. From these values,  at 10° can be obtained by using
the relationships outlined in the mathematical model. The correction for losses during an 8
min wash at about 10° indicate that before oligomer-stained cells were washed only about
15 % of the TCR molecules on splenic CD8pos T cells and about 40 % of those on the T cell
hybridomas were engaged by the SA-oligomers at the highest oligomer concentrations tested
(Fig.1B,C and Table II).
The extent to which bound oligomers are lost by dissociation from stained cells varies with
the decay constant (koff,app) and the time spent preparing cells for flow cytometry (Fig. 3C).
Since  and intrinsic TCR-pMHC affinity (KD) are correlated (Table III, (12, 16, 18, 19,
26)), these losses are negligible for the engineered high affinity TCR. But for lower-affinity
TCR, such as the 2C TCR with the Y48 or S51/Y48 mutations, about 80 to 90% of bound
oligomers would be lost under conditions that are commonly used to prepare oligomer-
stained cells for flow cytometry.
CD8 effect on TCR-pMHC binding
From Fig 3, it is evident that the presence of CD8αβ on the cells led to slower oligomer
dissociation. For the wild-type 2C TCR on the CD8neg hybridoma, dissociation was so fast
that the rate could hardly be measured. However, with CD8pos hybridoma that expressed the
same TCR at about the same level, t½,app increased to over two minutes (Fig. 3A and inset
panel). For hybridomas that expressed the high-affinity m33 TCR, the oligomer dissociation
half-time increased from 5.9 min on CD8neg cells to 8.5 min on CD8pos cells (Fig.3B). To
compare T cell hybridomas with T cells freshly isolated from mice, CD8pos T cells from
Rag−/− 2C TCR transgenic splenocytes were examined side-by-side with CD8neg m33
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TCR+ hybridomas (Fig. 3B). Interestingly, the oligomer off-rate was nearly identical for the
two cell types, despite marked differences in TCR affinities, TCR densities, and CD8
expression.
Why do oligomers dissociate more slowly from CD8pos 2C T cells than from CD8pos
hybridomas that express the same TCR (t½,app = 5.85 min and 2.1 min, respectively, Figs.
3A,B)? The answer likely lies in the much greater number of TCR per cell on the CD8pos T
cells (about 56,000/cell on the CD8pos T cells vs. about 25,000/cell on the CD8pos
hybridoma cells, Table I). Moreover, the splenic CD8pos T cell diameter is about one-third
that of hybridomas (Fig. 2E,F). These differences mean that the cell-surface TCR density is
on average about 20-fold greater on the splenic T cells than on the hybridomas (188/μm2 vs.
8/μm2), resulting in the larger multivalent on-rate (μ) and smaller  (larger t½,app) on the
T cells. This average density found on normal and transgenic T cells is consistent with what
has been observed previously (42). Precise measurements of density are difficult, however,
as the membranes of lymphocytes are not simple spheres (43), and local variations in TCR
density are expected (reviewed in (44)), which could influence binding properties. Since the
intrinsic koff rate is expected to be the same from the 2C TCR, whether expressed by splenic
T cells or the transduced hybridomas, the greater stability of the SA-oligomers on the
splenic T cells can be attributed to the faster on-rate (μ) on the T cells.
Oligomer equilibrium binding constants (KD,olig)
Although cell-bound pMHC oligomers do not saturate cognate cell-surface TCR, the
titration curves in Figs.1B,C indicate that they saturate a subset of these TCR (19). For this
subset, the processes that occur on oligomer binding at steady state can be represented as:
(4)
where all the terms are defined as in Eq. 1 except for k’on, which refers to the on-rate for the
1st pMHC of the oligomer to bind. We take k’on to be the monomeric pMHC-TCR on-rate
(measured for example by SPR), except for a statistical factor that takes into account the
number of pMHC per oligomer (three in the present case). The binding data can be treated
according to the Langmuir adsorption isotherm to obtain an expression for the fraction of
cell-surface sites (i.e., TCR) occupied by the pMHC oligomers as a function of the free
oligomer concentration. Accordingly,
(5)
where Lsol is the concentration of oligomers in solution, and θ is the fraction of sites
occupied by oligomers (singly, doubly, or triply bound). In deriving Eq. 5 (see Appendix A),
we have assumed that the concentration of oligomers in solution is essentially equal to the
initial oligomer concentration and that this approximation is valid when the latter quantity is
relatively large.
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From the titration shown in Fig. 1C, the apparent affinity (KD,olig) of the 2C TCR on splenic
CD8pos T cells for SA-SIY/Kb oligomers is about 1 nM, as determined by the free oligomer
concentration at 50% maximum bound. Comparisons of KD,olig to monovalent KD are useful
to demonstrate the benefits of multivalent ligand binding to TCR -- e.g., the KD,olig/KD ratio
has been termed an enhancement factor (19, 45).
Discussion
This study confirms previous indications that SA-based pMHC oligomers (tetramers) bind
stably to only a fraction of cognate cell surface TCR (19). The fraction amounted to about
15% of the TCR on CD8pos splenic T cells from 2C TCR transgenic mice and about 40% on
a TCR-transduced hybridoma line. These less-than-saturating levels arise in part from losses
of bound oligomers when oligomer-stained cells are washed. The extent of these losses
depends on the dissociation or decay constant, , which is related to TCR-pMHC affinity
((Fig. 3C and Eq.2). For T cells whose TCR binds oligomers weakly (large ), nearly all
bound oligomers may be lost by dissociation when cells are subjected to commonplace
washing conditions. This effect could account for reports of “tetramer-negative” functionally
competent CD8pos T cells (9-12). Losses of bound oligomers by dissociation from low
affinity TCR may also well account for the recent report of a surprisingly high frequency of
CD4pos T cells that respond specifically to pMHC but are not stained by the corresponding
tetramers (13). The frequency of such tetramer-negative, functionally competent T cells
would be expected to be higher in CD4pos than in CD8pos T cell populations because of
differences in their co-receptor ectodomain binding to MHC: CD8 generally binds weakly to
class I MHC but CD4 binds hardly at all to class II MHC (46, 47).
It is likely that the oligomers bind stably (multivalently) only to those TCR molecules that
are closely clustered. The spacing between biotin (pMHC) binding sites on streptavidin is
2-4 nm (48), whereas TCR, if uniformly distributed on the cell surface, would generally be
much further apart (separated on average by about 60-70 nm on a T cell of 8.5 μm diameter
with 56,000 TCR molecules per cell (Table I and Fig.2E)). But cell-surface TCR, like many
other integral membrane proteins, are aggregated into groups (“islands”), some depending
upon cholesterol (lipid rafts) for their clustering (15, 49-51); reviewed in (52). Whether the
SA oligomers bind selectively to particular TCR clusters is not clear. The stronger binding
of pMHC dimers to activated than naïve T cells, and abolition of this difference by reducing
cholesterol content of the cell membranes (15) indicates that oligomer binding has the
potential to be developed into a useful procedure to define the size and character of TCR
clusters on cells that differ functionally or in developmental status.
For the TCR subset that can stably engage SA oligomers, an apparent equilibrium constant
for the oligomer-TCR interaction (KD,olig) can be defined as the free SA oligomer
concentration that leads to half-saturation of that TCR subset (Eq.5), the main uncertainty
being the maximum level. From the titration shown in Fig. 1C, KD,olig is about 1 nM for the
2C TCR-SIY/Kb oligomer interaction on CD8pos T cells. This value is compared in Table IV
with others measured for the same TCR (2C) and the same antigen (SIY/Kb complex) under
different conditions. The values range from about 30 μM (in the micromolar range
commonly found by SPR for many recombinant TCR and pMHC pairs) to a 300-fold higher
affinity for the binding of soluble SIY-Kb monomer to the 2C TCR and CD8 on intact
CD8pos T cells and the much higher values found with Ig-based dimers and SA-oligomers
on CD8pos T cells. Although the presumably clustered TCR molecules that bind SA
oligomers stably (multivalently) constitute a small fraction of all cell surface TCR (41), they
and non-clustered TCR have the same intrinsic (monovalent) affinity. This uniformity is
indicated by the linearity of Scatchard plots (1, 15) and by the Sips distribution (53).
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The binding of pMHC oligomers to cell-surface TCR approximates more closely than the
other conditions in Table IV to the quasi 2-dimensional interactions that occur under
physiological conditions at the interface of T cells and target cells or other antigen-
presenting cells. Recent studies have reported the kinetics of such 2-D interactions to be
exceptionally fast and their apparent affinities much higher than for the same interactions
under 3-D conditions (2, 3).
Finally, it is worth commenting on the contribution of CD8αβ in the trimolecular CD8-
pMHC-TCR reaction. Experimental findings (32) and computational analysis (46) concur in
showing that the CD8 ectodomain’s binding to the MHC α3 domain increases the lifetime of
the TCR-pMHC bond only modestly, two-fold at most. For SA-linked oligomers, which are
effectively trimeric, the CD8 effect can be increased up to eight-fold since  is
proportional to (koff)3 (Eq.2, (32, 46)). The CD8 effect on hybridomas that expressed the
high-affinity TCR (m33) is consistent with these values: t1/2 is about 1.4-fold greater for the
CD8pos than CD8neg cells (Fig. 3A) But for hybridomas that express the lower affinity 2C
TCR, t1/2 is 20-fold greater for the CD8pos than the CD8neg cells, which exceeds the
estimated upper limit of eight and reflects the greater dissociative losses of bound oligomers
from relatively low-affinity TCR (Fig. 3C). The still far greater difference, around 50-fold,
between the CD8neg hybridoma and CD8pos splenic T cells that express the same TCR (2C)
(t1/2 ca 0.1min vs 5.85 min), likely arises from the additional effect of the approximately 20-
fold greater surface density of the TCR on the splenic T cells, resulting in an increase in the
multivalent on-rate (μ) and from the proportionality of  to  (Eq. 2).
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Appendix A: Model Equations
Dissociation of bound oligomers
(Scheme 1)
where T refers to available TCR sites on the cell surface, L≡T is the number of oligomers
bound by three pMHC complexes, L=T is the number bound by two pMHCs, and L-T is the
number bound by one pMHC, Dissociation of L-T loses oligomers into solution (Lsol).
We assume that for each pMHC-TCR interaction, koff and μ (the multivalent on rate, see
text) are independent of the binding of neighboring MHC with TCR. Thus, stochiometric
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coefficients in front of koff and μ correspond to the number of pMHCs available for binding/
unbinding.
The following differential equations were used to describe interconversion among bound
forms and loss of bound forms in accord with scheme (1):
(A1)
(A2)
(A3)
Derivation of Text-Equations (2) and (5)
Text-Equation (2)
Concentration of oligomers (L) bound to cell-surface TCR (T) is equal to the sum of all
bound forms:
(A4)
Loss of bound oligomers is determined by dissociation of the singly bound form:
(A5)
As our oligomer dissociation data exhibit exponential decay kinetics, we can safely assume
a rapid equilibrium and interconvertibility (mass equilibrium) of bound forms, as has been
assumed previously (32). Applying this assumption, we get:
(A6)
(A7)
Plugging in (A6-7) to (A4):
(A8)
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Plugging (A8) in to (A5) yields:
(Text-Eq. 2)
where the approximate equality can be applied under the conditions where μ >> koff, as is
true for all of the interactions described here. Where μ ≤ koff, the roots of the quadratic
equation for μ can be solved.
Derivation of Text Eq. 5
At equilibrium, the rate of oligomer association is equal to the rate of oligomer dissociation:
where k’on is on-rate (kon) for the monomeric pMHC-TCR interaction, as measured for
instance by SPR, modified by the number of pMHC per strepavidin molecule.
If θ is taken to be the fraction of occupied receptors, Tfree = (1 − θ)Ttotal and Lbound = θTtotal
and Eq (5) from the main text then follows:
Eq.5 resembles the Scatchard equation. That equation, arguably the most widely used one in
immunology, was originally developed (30) to account for the equilbrium binding of small
molecules and ions to proteins. For ligand-protein interactions, it is usually expressed as r/
(n-r) = Kc, where r represents moles bound ligand, n the moles of ligand maximally bound,
c the free ligand concentration, and K the equilibrium (association) constant. Independent
derivations of Scatchard’s equation have generally been based upon the distribution of
bound and free ligands at equilibrium (29, 31). In contrast, Eq.5 above was derived from the
kinetics of multivalent ligand binding to cell surface receptors. If, however, Eq.5 were
applied to monovalent ligand-receptor interactions, μ would become zero, kon’ would
correspond to the intrinsic association rate, kon, and Eq. 5 would then be equivalent to the
Scatchard equation.
References
1. Sykulev Y, Brunmark A, Tsomides TJ, Kageyama S, Jackson M, Peterson PA, Eisen HN. High-
affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic
and syngeneic major histocompatibility complex class I proteins. Proc Natl Acad Sci U S A. 1994;
91:11487–11491. [PubMed: 7972089]
2. Huang J, Zarnitsyna VI, Liu B, Edwards LJ, Jiang N, Evavold BD, Zhu C. The kinetics of two-
dimensional TCR and pMHC interactions determine T-cell responsiveness. Nature. 2010; 464:932–
936. [PubMed: 20357766]
3. Huppa JB, Axmann M, Mortelmaier MA, Lillemeier BF, Newell EW, Brameshuber M, Klein LO,
Schutz GJ, Davis MM. TCR-peptide-MHC interactions in situ show accelerated kinetics and
increased affinity. Nature. 2010; 463:963–967. [PubMed: 20164930]
4. Dal Porto J, Johansen TE, Catipovic B, Parfiit DJ, Tuveson D, Gether U, Kozlowski S, Fearon DT,
Schneck JP. A soluble divalent class I major histocompatibility complex molecule inhibits
Stone et al. Page 13
J Immunol. Author manuscript; available in PMC 2012 December 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
alloreactive T cells at nanomolar concentrations. Proc Natl Acad Sci U S A. 1993; 90:6671–6675.
[PubMed: 8341685]
5. Serbina N, Pamer EG. Quantitative studies of CD8+ T-cell responses during microbial infection.
Curr Opin Immunol. 2003; 15:436–442. [PubMed: 12900276]
6. Vollers SS, Stern LJ. Class II major histocompatibility complex tetramer staining: progress,
problems, and prospects. Immunology. 2008; 123:305–313. [PubMed: 18251991]
7. Xu XN, Screaton GR. MHC/peptide tetramer-based studies of T cell function. J Immunol Methods.
2002; 268:21–28. [PubMed: 12213339]
8. Altman JD, Moss PA, Goulder PJ, Barouch DH, McHeyzer-Williams MG, Bell JI, McMichael AJ,
Davis MM. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996; 274:94–96.
[PubMed: 8810254]
9. Burrows SR, Kienzle N, Winterhalter A, Bharadwaj M, Altman JD, Brooks A. Peptide-MHC class I
tetrameric complexes display exquisite ligand specificity. J Immunol. 2000; 165:6229–6234.
[PubMed: 11086057]
10. Buslepp J, Zhao R, Donnini D, Loftus D, Saad M, Appella E, Collins EJ. T cell activity correlates
with oligomeric peptide-major histocompatibility complex binding on T cell surface. J Biol Chem.
2001; 276:47320–47328. [PubMed: 11584024]
11. Hernandez J, Lee PP, Davis MM, Sherman LA. The use of HLA A2.1/p53 peptide tetramers to
visualize the impact of self tolerance on the TCR repertoire. J Immunol. 2000; 164:596–602.
[PubMed: 10623800]
12. Laugel B, van den Berg HA, Gostick E, Cole DK, Wooldridge L, Boulter J, Milicic A, Price DA,
Sewell AK. Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern
cytotoxic T lymphocyte activation and tetramer binding properties. J Biol Chem. 2007;
282:23799–23810. [PubMed: 17540778]
13. Sabatino JJ Jr. Huang J, Zhu C, Evavold BD. High prevalence of low affinity peptide-MHC II
tetramer-negative effectors during polyclonal CD4+ T cell responses. J Exp Med. 2011; 208:81–
90. [PubMed: 21220453]
14. Busch DH, Pamer EG. T cell affinity maturation by selective expansion during infection. J Exp
Med. 1999; 189:701–710. [PubMed: 9989985]
15. Fahmy TM, Bieler JG, Edidin M, Schneck JP. Increased TCR avidity after T cell activation: a
mechanism for sensing low-density antigen. Immunity. 2001; 14:135–143. [PubMed: 11239446]
16. Holmberg K, Mariathasan S, Ohteki T, Ohashi PS, Gascoigne NR. TCR binding kinetics measured
with MHC class I tetramers reveal a positive selecting peptide with relatively high affinity for
TCR. J Immunol. 2003; 171:2427–2434. [PubMed: 12928390]
17. Slifka MK, Whitton JL. Functional avidity maturation of CD8(+) T cells without selection of
higher affinity TCR. Nat Immunol. 2001; 2:711–717. [PubMed: 11477407]
18. Crawford F, Kozono H, White J, Marrack P, Kappler J. Detection of antigen-specific T cells with
multivalent soluble class II MHC covalent peptide complexes. Immunity. 1998; 8:675–682.
[PubMed: 9655481]
19. Chervin AS, Stone JD, Holler PD, Bai A, Chen J, Eisen HN, Kranz DM. The impact of TCR-
binding properties and antigen presentation format on T cell responsiveness. J Immunol. 2009;
183:1166–1178. [PubMed: 19553539]
20. Udaka K, Wiesmuller KH, Kienle S, Jung G, Walden P. Self-MHC-restricted peptides recognized
by an alloreactive T lymphocyte clone. J Immunol. 1996; 157:670–678. [PubMed: 8752916]
21. Holler PD, Chlewicki LK, Kranz DM. TCRs with high affinity for foreign pMHC show self-
reactivity. Nat Immunol. 2003; 4:55–62. [PubMed: 12469116]
22. Shusta EV, Holler PD, Kieke MC, Kranz DM, Wittrup KD. Directed evolution of a stable scaffold
for T-cell receptor engineering. Nat Biotechnol. 2000; 18:754–759. [PubMed: 10888844]
23. Garcia KC, Tallquist MD, Pease LR, Brunmark A, Scott CA, Degano M, Stura EA, Peterson PA,
Wilson IA, Teyton L. Alphabeta T cell receptor interactions with syngeneic and allogeneic
ligands: affinity measurements and crystallization. Proc Natl Acad Sci U S A. 1997; 94:13838–
13843. [PubMed: 9391114]
Stone et al. Page 14
J Immunol. Author manuscript; available in PMC 2012 December 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
24. Jones LL, Colf LA, Stone JD, Garcia KC, Kranz DM. Distinct CDR3 conformations in TCRs
determine the level of cross-reactivity for diverse antigens, but not the docking orientation. J
Immunol. 2008; 181:6255–6264. [PubMed: 18941216]
25. Zhang B, Bowerman NA, Salama JK, Schmidt H, Spiotto MT, Schietinger A, Yu P, Fu YX,
Weichselbaum RR, Rowley DA, Kranz DM, Schreiber H. Induced sensitization of tumor stroma
leads to eradication of established cancer by T cells. J Exp Med. 2007; 204:49–55. [PubMed:
17210731]
26. Savage PA, Boniface JJ, Davis MM. A kinetic basis for T cell receptor repertoire selection during
an immune response. Immunity. 1999; 10:485–492. [PubMed: 10229191]
27. Rosette C, Werlen G, Daniels MA, Holman PO, Alam SM, Travers PJ, Gascoigne NR, Palmer E,
Jameson SC. The impact of duration versus extent of TCR occupancy on T cell activation: a
revision of the kinetic proofreading model. Immunity. 2001; 15:59–70. [PubMed: 11485738]
28. Daniels MA, Teixeiro E, Gill J, Hausmann B, Roubaty D, Holmberg K, Werlen G, Hollander GA,
Gascoigne NRJ, Palmer E. Thymic selection threshold defined by compartmentalization of Ras/
MAPK signalling. Nature. 2006; 444:724–729. [PubMed: 17086201]
29. Eisen, HN. Immunology. Harper & Row, Publishers, Inc.; Hagerstown, Maryland: 1974. p.
403derivation by B. Altschuler
30. Scatchard G. The Attraction of Proteins for Small Molecules and Ions. Annals of the New York
Academy of Sciences. 1949; 51:660–672.
31. Schreier AA, Schimmel PR. Interaction of manganese with fragments, complementary fragment
recombinations, and whole molecules of yeast phenylalanine specific transfer RNA. J Mol Biol.
1974; 86:601–620. [PubMed: 4604622]
32. Wooldridge L, van den Berg HA, Glick M, Gostick E, Laugel B, Hutchinson SL, Milicic A,
Brenchley JM, Douek DC, Price DA, Sewell AK. Interaction between the CD8 coreceptor and
major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell
surface. J Biol Chem. 2005; 280:27491–27501. [PubMed: 15837791]
33. Anikeeva N, Mareeva T, Liu W, Sykulev Y. Can oligomeric T-cell receptor be used as a tool to
detect viral peptide epitopes on infected cells? Clin Immunol. 2009; 130:98–109. [PubMed:
18845488]
34. Cameron TO, Norris PJ, Patel A, Moulon C, Rosenberg ES, Mellins ED, Wedderburn LR, Stern
LJ. Labeling antigen-specific CD4(+) T cells with class II MHC oligomers. J Immunol Methods.
2002; 268:51–69. [PubMed: 12213343]
35. Wang R, Natarajan K, Margulies DH. Structural basis of the CD8 alpha beta/MHC class I
interaction: focused recognition orients CD8 beta to a T cell proximal position. J Immunol. 2009;
183:2554–2564. [PubMed: 19625641]
36. Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW. The organizing principle in the formation
of the T cell receptor-CD3 complex. Cell. 2002; 111:967–979. [PubMed: 12507424]
37. Fernandez-Miguel G, Alarcon B, Iglesias A, Bluethmann H, Alvarez-Mon M, Sanz E, de la Hera
A. Multivalent structure of an alphabetaT cell receptor. Proc Natl Acad Sci U S A. 1999; 96:1547–
1552. [PubMed: 9990061]
38. Kuhns MS, Girvin AT, Klein LO, Chen R, Jensen KD, Newell EW, Huppa JB, Lillemeier BF,
Huse M, Chien YH, Garcia KC, Davis MM. Evidence for a functional sidedness to the
alphabetaTCR. Proc Natl Acad Sci U S A. 2010; 107:5094–5099. [PubMed: 20202921]
39. Schrum AG, Gil D, Turka LA, Palmer E. Physical and functional bivalency observed among TCR/
CD3 complexes isolated from primary T cells. J Immunol. 2011; 187:870–878. [PubMed:
21666056]
40. Campi G, Varma R, Dustin ML. Actin and agonist MHC-peptide complex-dependent T cell
receptor microclusters as scaffolds for signaling. J Exp Med. 2005; 202:1031–1036. [PubMed:
16216891]
41. Schamel WW, Arechaga I, Risueno RM, van Santen HM, Cabezas P, Risco C, Valpuesta JM,
Alarcon B. Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide
range of response. J Exp Med. 2005; 202:493–503. [PubMed: 16087711]
42. Carpentier B, Pierobon P, Hivroz C, Henry N. T-cell artificial focal triggering tools: linking
surface interactions with cell response. PLoS One. 2009; 4:e4784. [PubMed: 19274104]
Stone et al. Page 15
J Immunol. Author manuscript; available in PMC 2012 December 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
43. Alexander EL, Wetzel B. Human lymphocytes: similarity of B and T cell surface morphology.
Science. 1975; 188:732–734. [PubMed: 1079095]
44. Hartman NC, Groves JT. Signaling clusters in the cell membrane. Curr Opin Cell Biol. 2011;
23:370–376. [PubMed: 21665455]
45. Hornick CL, Karush F. The interaction of hapten-coupled bacteriophage phi-X-174 with antihapten
antibody. Isr J Med Sci. 1969; 5:163–170. [PubMed: 5803754]
46. Artyomov MN, Lis M, Devadas S, Davis MM, Chakraborty AK. CD4 and CD8 binding to MHC
molecules primarily acts to enhance Lck delivery. Proc Natl Acad Sci U S A. 2010; 107:16916–
16921. [PubMed: 20837541]
47. Xiong Y, Kern P, Chang H, Reinherz E. T Cell Receptor Binding to a pMHCII Ligand Is
Kinetically Distinct from and Independent of CD4. J Biol Chem. 2001; 276:5659–5667. [PubMed:
11106664]
48. Hendrickson WA, Pahler A, Smith JL, Satow Y, Merritt EA, Phizackerley RP. Crystal structure of
core streptavidin determined from multiwavelength anomalous diffraction of synchrotron
radiation. Proc Natl Acad Sci U S A. 1989; 86:2190–2194. [PubMed: 2928324]
49. Edidin M. The state of lipid rafts: from model membranes to cells. Annu Rev Biophys Biomol
Struct. 2003; 32:257–283. [PubMed: 12543707]
50. Lillemeier BF, Mortelmaier MA, Forstner MB, Huppa JB, Groves JT, Davis MM. TCR and Lat are
expressed on separate protein islands on T cell membranes and concatenate during activation. Nat
Immunol. 2010; 11:90–96. [PubMed: 20010844]
51. Lillemeier BF, Pfeiffer JR, Surviladze Z, Wilson BS, Davis MM. Plasma membrane-associated
proteins are clustered into islands attached to the cytoskeleton. Proc Natl Acad Sci U S A. 2006;
103:18992–18997. [PubMed: 17146050]
52. Levental I, Grzybek M, Simons K. Greasing their way: lipid modifications determine protein
association with membrane rafts. Biochemistry. 2010; 49:6305–6316. [PubMed: 20583817]
53. Cho BK, Lian KC, Lee P, Brunmark A, McKinley C, Chen J, Kranz DM, Eisen HN. Differences in
antigen recognition and cytolytic activity of CD8(+) and CD8(−) T cells that express the same
antigen-specific receptor. Proc Natl Acad Sci U S A. 2001; 98:1723–1727. [PubMed: 11172018]
Stone et al. Page 16
J Immunol. Author manuscript; available in PMC 2012 December 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1. MHC Oligomer Staining of Retrovirally-Transduced T Cell Hybridomas
(A) Distribution of oligomeric species in oligomer (tetramer) preparations. Reduced,
unboiled gradient SDS-PAGE gel of reaction of different molar ratios of biotinylated H2-Kb
and streptavidin. The Kb is biotinylated site-specifically on the heavy chain concurrently
with translation by biotin ligase-expressing E. coli, with a modification efficiency of
approximately 50%. Following experiments carried out using reagent corresponding to 16:1
MHC:streptavidin ratio. (B) Steady-state oligomer staining of T cell hybridomas with and
without CD8αβ expression—corrected by subtracting fluorescence of 58−/− cells without
TCR or CD8 at the same conditions. (C) Steady-state staining of 2C transgenic T cells
carried out at 4°C using various concentrations of SIY/Kb:streptavidin oligomer. Binding of
SIY/Kb:streptavidin oligomer to C57BL/6 T cells was subtracted from binding to 2C
transgenic T cells. Quantification of molecules per cell indicates number of fluorescent
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streptavidins associated with the cell; actual number of MHC-bound TCRs may be up to
three times higher.
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Figure 2. Detection of T Cell Receptor and CD8 Epitopes on T cell hybridomas and transgenics
Quantification of molecules per cell is derived from flow cyotometry staining data using
calibrated, fluorescein-labeled antibodies and comparing to two independent batches of
fluorescein-labeled beads. (A-D) Staining of cell-surface epitopes including (A,C) TCR Cβ
(clone H57-597), TCR Vβ8 (clone F23.1), CD3ε (clone 145-2C11), the 2C TCR specifically
(clone 1B2), and (B,D) CD8α (clone 53-6.7) and CD8β (clone 53-5.8) on (A,B) T cell
hybridomas or (C,D) mouse T cells. Error bars represent the standard deviation for at least 2
and up to 8 repetitions for each individual measurement. (E,F) Contrast images showing the
size differences between (E) mouse T cells (2C TCR transgenic) and (F) T cell hybridomas
(m33 TCR).
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Figure 3. MHC Oligomer Dissociation from T Cells
(A-B) Remaining associated fluorescent pMHC oligomer measurements were made for (A)
2C hybridomas with (open triangles) or without (closed circles) CD8 (highlighted in inset),
and m33 with (open squares) or without (closed diamonds) CD8. (B) 2C TCR transgenic T
cells (closed circles) and m33 hybridomas (CD8 negative, open diamonds). Dissociation
data for (A-B) were fit by the equation describing a first order exponential decay. (C)
Simulated effect of dissociation of bound oligomers on washing the cells over a 4, 8, or 12
min period in the cold (4°-10°) prior to flow cytometry, showing the effect of koff,app on the
level of persisting oligomers. Vertical bars indicate approximate koff,app values calculated
for different 2C receptor mutants.
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Table IV
Equilibrium constants (KD) for 2C TCR binding the SIY/K
b (pMHC) complex measured under various
conditionsa.
Assay conditions KD (μM) Reference
Soluble, recombinant 2C TCR and SIY/Kb
  Surface plasmon resonance
32 (23)
27 (24)
36 (19)
Soluble monomeric SIY/Kb
  Inhibition of 125I-Fab 1B2 binding to CD8+ T
  cells
0.1 (54)
0.33 (53)
Dimeric SIY/Kb-IgG binding to:
  naïve 2C transgenic T cells
  activated 2C transgenic T cells
0.004 (4°C) (15)
0.077 (37°C) ‘ ’
0.001 (4°C) ‘ ’
0.064 (37°C) ‘ ’
Streptavidin-oligomers of SIY/Kb binding to:
  CD8− 2C T cell hybridomas
  CD8+ 2C T cell hybridomas
  CD8− m33 T cell hybridomas
  CD8+ m33 T cell hybridomas
  CD8+ 2C transgenic splenic T cells
0.011 (19)
0.0041 b
0.0023 b
0.0010 b
0.0016 b
0.0016 b
a
Measurements at 25°C unless otherwise indicated
b
Values measured in current work
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